NCT04582487 2024-02-07
Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Unknown
Clinical Trials
14 trialsNCT05576532 2023-06-28
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT05832125 2023-04-27
ALLTARGETOBS
Versailles Hospital
Unknown
NCT05596266 2022-10-27
CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia
Xuanwu Hospital, Beijing
Phase 1 Unknown
NCT05277753 2022-03-15
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
Shenzhen Geno-Immune Medical Institute
Phase 1 Unknown
NCT04679506 2020-12-22
the Efficacy and Safety of CLAE in R/R T-ALL/LBL
Peking University Third Hospital
Unknown
NCT04620655 2020-11-09
RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL
Hebei Yanda Ludaopei Hospital
Phase NA Unknown
NCT04446130 2020-06-24
Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT04437420 2020-06-23
HSP-HEMATO
Centre Hospitalier Universitaire Dijon
Unknown
NCT04320992 2020-03-26
A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma
Sun Yat-sen University
Unknown
NCT04008394 2019-08-07
Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Unknown
NCT03558412 2018-09-14
A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT03613428 2018-08-03
Ruxolitinib Plus LVP in Patients With R/R ETP-ALL
Sichuan University
Phase 1/2 Unknown
NCT00882011 2011-10-13
Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
Fondazione Italiana Linfomi - ETS
Unknown